Publications by authors named "Rowan Faber"

Claim this Profile
A
Adverse Event Following Change in Brachytherapy Plaque-Cleaning Chemicals: A Case Series.
Jesintha Navaratnam, Thomas Bærland, Ola Nilsen, Bernt Rekstad, Rowan Faber

Ocul Oncol Pathol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizations of uveal melanoma patients with three additional primary malignancies.
Nils Andreas Eide, Rowan Thomas Faber, Øystein Garred, Ragnhild Sørum Falk, Trude Eid Robsahm

Acta Ophthalmol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macular hole Delphi consensus statement (MHOST).
Filippo Confalonieri, Hanna Haave, Susanne Binder, Agnieszka Monika Bober, Ragnheidur Bragadottir, Rowan Faber

Acta Ophthalmol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary vitrectomy or intravitreal antibiotics followed by early vitrectomy for acute endophthalmitis: A prospective observational study.
Kathrine Blom, Øystein Kalsnes Jørstad, Rowan Thomas Faber, Ingar Stene-Johansen, Mona Holberg-Petersen

Acta Ophthalmol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fundus Autofluorescence Change as an Early Indicator of Treatment Effect of Brachytherapy for Choroidal Melanomas.
Jesintha Navaratnam, Thomas P Bærland, Nils A Eide, Rowan T Faber, Bernt L Rekstad

Ocul Oncol Pathol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Results of Stricter Inclusion Criteria in an Immunomagnetic Detection Study of Micrometastatic Cells in Bone Marrow of Uveal Melanoma Patients - Relevance for Dormancy.
Nils Eide, Ragnar S Faye, Hanne K Høifødt, Leiv Sandvik, Geir A Qvale, Rowan Faber

Pathol Oncol Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year functional and anatomical results after converting treatment resistant eyes with exudative age-related macular degeneration to aflibercept in accordance with a treat and extend protocol.
Øystein Kalsnes Jørstad, Rowan Thomas Faber, Morten Carstens Moe

Acta Ophthalmol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial improvements when converting eyes with treatment-resistant exudative AMD to aflibercept are substantially diminished after increasing treatment intervals from 4 to 8 weeks.
Øystein Kalsnes Jørstad, Rowan Thomas Faber, Morten Carstens Moe

Acta Ophthalmol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomagnetic detection of micrometastatic cells in bone marrow of uveal melanoma patients: a paradox.
Nils Eide, Ragnar S Faye, Hanne K Høifødt, Berit Sandstad, Geir Qvale, Rowan Faber

Acta Ophthalmol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disseminated tumour cells in bone marrow of patients with uveal melanoma.
Nils Eide, Hanne K Hoifødt, Jahn M Nesland, Ragnar S Faye, Geir A Qvale, Rowan T Faber

Acta Ophthalmol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis